Extradigestive Manifestations of Helicobacter pylori Infection (Fact and Fiction) (original) (raw)

REFERENCES

  1. Nedrud JG, Czinn SJ: Helicobacter pylori. Curr Opin Gastroenterol 13:71–78, 1997
    Google Scholar
  2. Graham DY, Hepps KS, Ramirez FC, Lew GM, Saeed ZA: Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease. Scand J Gastroente rol 28:939–942, 1993
    Google Scholar
  3. Treiber G, Lambert JR: The impact of Helicobacter pylori e radication on pepticulcer healing. Am J Gastroenterol 93:1080–1084, 1998
    Google Scholar
  4. Walsh JH, Peterson WL: The treatment of Helicobacter pylori infection in the management of pepticulcer disease. N Engl J Med 333:984–991, 1995
    Google Scholar
  5. Xiang Z, Censini S, Bayeli PF, Telford JL, Figura N, Rappuoli R, Covacci A: Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that the clinical isolates can be divided into two major type s and that CagA is not necessary for expression of the vacuolating toxin. Infect Immun 63:94–98, 1995
    Google Scholar
  6. Patel P, Gasbarrini G, Pretolani S, Gasbarrini A, France schi F: Extradigestive diseases and Helicobacter pylori infection. Curr Opin Gastroenterol 13:52–55, 1997
    Google Scholar
  7. Canino V, Massa F, Bonardi L: Osservazioni morfologiche sullearterie gastriche di pazienti affetti da ulcera gastroduodenale. Arch Sci Med 133:109–112, 1976
    Google Scholar
  8. Raso AM, Rispoli P, Sisto G, Castagno PL: Direct Surgery of lesions of the femoropoplite altract. Indications and treatment. Minerva Cardioarigiol 36:295, 1998
    Google Scholar
  9. Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, Camm AJ, Northfield TC: Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 71:437–439, 1994
    Google Scholar
  10. Fabricant CG, Fabricant J, Litrenta MM, Minick CR: Virusinduced atherosclerosis. J Exp Med 148:335–340, 1978
    Google Scholar
  11. Cook PJ, Lip GYH: Infectious age nts and atherosclerosis vascular disease. Q J Med 89:727–735, 1996
    Google Scholar
  12. Syrjaken J, Valtonen VV, Iivanainen M, Kaste M, Huttunen JK: Pre ceding infection as an important risk factor for ischaemic brain infarction in young and middle aged patients. BMJ 296:1156–1160, 1988
    Google Scholar
  13. Patel P, Mendall MA, Carrington D, Strachan DP, Leatham E, Molineaux N, Levy J, Blakeston C, Seymour CA, Camm AJ: Association of Helicobacter pylori and Chlamydia pn eumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ 311:711–714, 1995
    Google Scholar
  14. Ponzetto A, La Rovere MT, Sanseve rino P, Bazzoli F: Association of Helicobacter pylori infection with coronary heart disease BMJ 312:251, 1996
    Google Scholar
  15. Maier F, Auricchio A, Nilius M, Dominguez-Munoz J-E, Klein H, Malferthe iner P: Lack of association between Helicobacter pylori infection and angiographically documented coronary heart disease. Gut 39( suppl 2):A92, 1996 (abstract)
  16. Whincup PH, Mendall MA, Perry IJ, Strachan DP, Walker M: Prospective relations between Helicobacter pylori infection, coronary heart disease and stroke in middle age d men. Heart 75:568–572, 1996
    Google Scholar
  17. Dane sh J, Collins R, Peto R: Chronic Infections and coronary heart disease: Is there a link? Lancet 350:430–436, 1997
    Google Scholar
  18. Pasceri V, Cammarota G, Patti G, Cuoco L, Gasbarrini A, Grillo RL, Fedeli G, Gasbarrini G, Mase ri A: Association of virulent Helicobacter pylori strains with ischemic heart disease. Circulation 97:1675–1679, 1998
    Google Scholar
  19. Bierti L, Cernuschi C, Abbiati C, Beccari G, Di Battista R, Marchi R, Fede rici A, Bottasso B, Di Rocco N, de Franchis R: Correlation between gastric infection with Helicobacter pylori and plasma leve ls of fibrinogen, plasminogen activator inhibitor (PAI), and Von Willebrand factor (vWF) antigen. Gut 39( suppl):A90, 1996 (abstract)
    Google Scholar
  20. Mendall MA, Pate l P, Ballam L, Strachan D, Northfi e ld TC: C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 312:1061–1065, 1996
    Google Scholar
  21. Mendall MA, Patel P, Ballam L, Morris J, Strachan DP, Camm AJ, North field TC: Relation of se rum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart 78:273–277, 1997
    Google Scholar
  22. Lip GYH, Wise R, Be eve rs G: Study shows association between Helicobacter pylori infection and hypertension. BMJ 312:250–251, 1996
    Google Scholar
  23. Nieme la S, Karttunen T, Korhonen T, Laara E, Karttunen R, Ikahe imo M, Ke saniemi YA: Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying se rum lipid concentrations? Heart 75:573–575, 1996
    Google Scholar
  24. Phull P, Gower J, Price A, Green C, Jacyna M: Alphatocopherol antioxidant levels in chronic gastritis: Correlation with mucosal neutrophil infi ltration. Gut 34( suppl):S34, 1993
    Google Scholar
  25. Barton SGRG, Winrow VR, Rampton DS, Crabtree JE, Beale s ILP, Calam J: Circulating antibodies to the 60–kD heat shock protein (hsp) family in patients with Helicobacter pylori infection. Clin Exp Immunol 112:490–494, 1998
    Google Scholar
  26. Sung JIY, Sanderson JE: Hyperhomocyste inemia, Helicobacter pylori and coronary heart disease. Heart 76:306–307, 1996
    Google Scholar
  27. Blasi F, Denti F, Erba M, Cosentini R, Raccanelli R, Rinaldi A, Fagetti L, Esposito G, Ruberti U, Allegra L: De tection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysm. J Clin Microbiol 34:2766–2769, 1996
    Google Scholar
  28. Elizalde JI, Gome z J, Pane s J, Lozano M, Casade vall M, Ramire z J, Pizcueta P, Marco F, Diaz de Rojas F, Grange r DN, PiqueÁ J: Platele t activation in mice and human Helicobacter pylori infection. J Clin Inve st 100:996–1005, 1997
    Google Scholar
  29. Gasbarrini A, Sericchio M, Tondi P, Gasbarrini G, Pola P: Association of Helicobac ter pylori infection with primary Raynaud phenomenon. Lance t 348:966–967, 1996
    Google Scholar
  30. Gasbarrini A, Massari M, Sericchio M, Tondi P, Sanz Torre E, De Luca A, Dal Lago A, Flore R, Santoliquido A, Gasbarrini G, Pola P: Helicobacter pylori and Raynaud phenomenon. Gastroente rol Int 10( suppl 1):18–19, 1997
    Google Scholar
  31. Crabtree JE: Immune and infl ammatory response to Helicobacter pylori infection. Scand J Gastroente rol 31( suppl 215):3–10, 1996
    Google Scholar
  32. Fredman JE, Fabian A, Loscalzo J: Impaired EDRF production by endothelial cells exposed to fi brin monomer and FDP. Am J Physiol 268:C520–C526, 1995
    Google Scholar
  33. Gasbarrini A, De Luca A, Fiore G, Ojetti V, Franceschi F, Di Campli C, Sanz Torre E, Candelli M, Massari I, Tondi PP, Serricchio M, Gasbarrini G, Pola P, Giacovazzo M: Helicobacter pylori and primary headache. Gastroenterol Int 10( suppl 1):11–13, 1997
    Google Scholar
  34. Mavromichalis I, Zaramboukas T, Giala MM: Migraine of gastrointestinal origin. Eur J Pediatr 154:406–410, 1995
    Google Scholar
  35. Figura N, Giordano N, Burroni D, Macchia G, Vindigni C, Gennari C, Bayeli PF: SjoÈ gren' s syndrome and Helicobacter pylori infection. Eur J Gastroenterol Hepatol 6:321–322, 1994
    Google Scholar
  36. Showji Y, Nozawa R, Sato K, Suzuki H: Seroprevalence of Helicobacter pylori infection in patients with connective tissue disease s. Microbiol Immunol 40:499–503, 1996
    Google Scholar
  37. Collin P, Karvone n AL, Korpela M, Laippala P, He lin H: Gastritis classifi ed in accordance with the Sidney system in patients with primary SjoÈ gren' s syndrome. Scand J Gastroenterol 32:108–111, 1997
    Google Scholar
  38. Re inauer S, Megahe d M, Goerz G: SchoÈnlein-Henoch purpura associated with gastric Helicobacter pylori infection. J Am Acad Dermatol 33:876–879, 1995
    Google Scholar
  39. Machet L, Vaillant L, Mache t MC, Buchler M, Lore tte G: SchoÈ nlein-Henoch purpura associated with gastric Helicobacter pylori infection. Dermatology 194:86, 1997
    Google Scholar
  40. Figura N, Guarino E, Gragnoli A, Di Cairano F, LoreÁ F, Cataldo D, Gennari C: H. pylori infection and thyroid disease s. Gut 39( suppl 2):A93, 1996 (abstract)
    Google Scholar
  41. Altschuler E: Gastric Helicobacter pylori infection as a cause of idiopathic Parkinson disease and non-arteric anterior optic ischaemic neuropaty. Med Hypothe ses 47:413–414, 1996
    Google Scholar
  42. Ne grini R, Lisato L, Zanella I, Cavazzini L, Gullini S, Villanacci V, Poiesi C, Albertini A, Ghielmi S: Helicobacter pylori infection induces antibodies cross-re acting with human gastric mucosa. Gastroente rology 101:437–445, 1991
    Google Scholar
  43. Ne grini R, Savio A, Poiesi C, Appelme lk BJ, Buffoli F, Pate rlini A, Cesari P, Graffeo M, Vaira D, Franzin G: Antigenic mimicry between H. pylori and gastric mucosa in the pathogenesis of body atrophic gastritis. Gastroenterology 111:655–665, 1996
    Google Scholar
  44. KolibaÁ sovaÁ K, CervenkovaÁ D, He gyi E, Lengye lovaÁ J, ToÁ th J: Helicobacter pylori: ein moÈ glicher aÈ tiologischer Faktor der chronischen Urticaria. Dermatosen 42:235–236, 1994
    Google Scholar
  45. Bohme yer J, He ller A, Hartig C, We tenberger-Treumann M, Huchzerme yer H, Otte HG, Stadler R: Assoziation der chronischen Urtikaria mit Helicobacter pylori induzierter Antrum-Gastritis. Hautarzt 47:106–108, 1996
    Google Scholar
  46. Tebbe B, Ge ilen CC, Schulzka JD, Bojarski C, Radenhausen M, Orfanos CE: Helicobacter pylori infection and chronic urticaria. J Am Acad De rmatol 34:685–686, 1996
    Google Scholar
  47. Di Campli C, Gasbarrini A, Nuce ra E, Franceschi F, Ojetti V, De Luca A, Massari I, Sanz Torre E, Candelli M, Schiavino D, Pola P, Gasbarrini G, Patriarca G: Helicobacter pylori Infection in Idiopathic Chronic Urticaria. Gastroenterol Int 10( suppl 1):48–49, 1997
    Google Scholar
  48. Gasbarrini A, Franceschi F, Ojetti V, De Luca A, Massari I, Cande lli M, Sanz Torre E, Gabrielli M, Canducci F, Pola P, Gasbarrini G: Extradige stive Diseases Associated with Helicobacter pylori Infection. Gastroenterol Int 10( suppl 4):27–32, 1997
    Google Scholar
  49. Rebora A, Drago F, Parodi A: May Helicobacter pylori be important for dermatologists? Dermatol 191:6–8, 1995
    Google Scholar
  50. Rebora A, Drago F, Picciotto A: Helicobacter pylori in patients with rosace a. Am J Gastroenterol 89:1603–1604, 1994
    Google Scholar
  51. Powell FC, Daw MA, Duguid C: Positive Helicobacter pylori se rology in rosace a patients. 5th Workshop on Gastroduodenal Pathology and Helicobacter pylori. Dublin, July 1992, PD 12
  52. Schne ider MA, Skinner RB Jr, Rosenberg EW, Noah IW, Smith L, Zwarum A: Serologic dete rmination of Helicobacter pylori in rosacea patients and controls. Clin Res 40:831A, 1992
    Google Scholar
  53. Sharma VK, Lynn A, Kaminski M, Vasudeva R, Howden CW: A study of the prevalence of H. pylori infection and other markers of upper gastrointestinal tract disease in patients with rosace a. Am J Gastroente rol 93:220–222, 1998
    Google Scholar
  54. KolibaÁ sovaÁ K, Tu thovaÁ I, Baumgartne r J, Filo V: Eradication of Helicobacter pylori as the only successful treatment in rosace a. Arch Dermatol 132:1393, 1996
    Google Scholar
  55. Tosti A, Pre tolani S, Figura N, Polini M, Cameli N, Cariani G, Miglio F, Bonvicini F, Baldini L, Gnucci E, Lucente P, Gasbarrini G: Helicobacter pylori and skin disease s. Gastroente rol Int 10( suppl 1):37–39, 1997
    Google Scholar
  56. Dufour C, Brisigotti M, Fabre tti G, Luxardo P, Mori PG, Barabino A: Helicobacter pylori gastric infection and sideropenic refractory anemia. J Pediatr Gastr Nutr 17:225–227, 1993
    Google Scholar
  57. Marignani M, Ange letti S, Bordi C, Malagnino F, Mancino C, Delle Fave G, Annibale B: Reversal of long-standing iron de® ciency anaemia after eradication of H. pylori infection. Scand J Gastroenterol 32:617–622, 1997
    Google Scholar
  58. Raymond J, Be rgere t M, Benhamou PH, Mensah K, Dupont C: A 2–year study of Helicobacter pylori in children. J Clin Microbiol 32:461–463, 1994
    Google Scholar
  59. Murch SH, Lamkin VA, Savage MO, Walker-Smith JA, Mac-Donald TT: Serum concentrations of tumor necrosis factor a in childhood chronic α in ammatory bowel disease. Gut 32:913–917, 1991
    Google Scholar
  60. Rosenstook SJ, Andersen LP, Bonnevie O, Jorge nsen T: Serum lipids, body indices, age of menarche and Helicobacter pylori infection in 1756 Danish women. Gut 39( suppl 3):A62, 1996 (abstract)
    Google Scholar
  61. Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M, Isaacson PG: Regre ssion of primary low-grade B-ce ll gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lance t 342:575–577, 1993
    Google Scholar
  62. Alkan S, Karche r DS, Newman MA, Cohen P: Regre ssion of salivary gland MALT lymphoma after treatment for Helicobacter pylori. Lancet 348:268–269, 1996
    Google Scholar
  63. Diss TC, Peng H, Wotherspoon AC, Pan L, Speight PM, Isaacson PG: Brief report: A single neoplastic clone in sequential biopsy specimens from a patient with primary gastricmucosa-associated-lymphoid-tissue lymphoma and SjoÈ gren' s syndrome. NEngl J Med 329:172–175, 1993
    Google Scholar
  64. Oldenburg B, Diepe raloot RJA, Hoekatra JBL: High se roprevalence of Helicobacter pylori in diabete s me llitus patients. Dig Dis Sci 41:458–461, 1996
    Google Scholar
  65. Perichizzi G, Bottari M, Pallio S, Fe ra MT, Carbone M, Barre si G: Gastric infection by H. pylori and antral gastritis in hype rglycemic obese and in diabetic subjects. New Microbiol 19:149–154, 1996
    Google Scholar
  66. Bilotta M, Pacifi co A, Malaty HM, Dore MP, Pisanu G, Maioli M, Realdi G: Seroprevalence of Helicobacter pylori in diabetic patients. Ital J Gastroente rol Hepatol 29( 2):A87, 1997 (abstract)
    Google Scholar
  67. Kao CH, Pan DY, Wang SJ, Chen GH: The relationship between H. pylori infection and gastirc emptying in patients with non-insulin-dependent diabete s me llitus. Eur J Nucl Med 22:122–125, 1995
    Google Scholar
  68. Miyaji H, Ito S, Azuma T, Yamazaki Y, Ohtaki Y, Sato F, Hirai M, Kuriyama M, Kohli Y: Effects of Helicobacter pylori eradication therapy on hype rammonaemi a in patients with liver cirrhosis. Gut 40:726–730, 1997
    Google Scholar
  69. Gubbins GP, Moritz TE, Marsano LS, Talwalkar R, Mc-Clain CJ, Mendenhall CL: H. pylori is a risk factor for hepatic encephalopathy in acute alcoholic hepatitis: the ammonia hypothesis re visited. The Ve terans Administrations Cooperative Study Group No. 275. Am J Gastroenterol 88:1906–1910, 1993
    Google Scholar

Download references